CIPAN-PORTUGAL

Company

Revenue (TTM)

Net income (TTM)

Market cap

Employees

Akers Biosciences, Inc.

1.09m

-2.78m

3.52m

4000

Angel Biotechnology Holdings Plc

--

--

2.31m

37

Ark Therapeutics Group plc

8.77m

-5.90m

2.44m

63

B.M.P. Pharma Trading AG

52.16k

207.12k

2.73m

35

ChronTech Pharma AB

-2.28m

4.61m

CIPAN - Cia Ind Prom de Ant SA

20.36K

50K

3.91m

146

Creative Antibiotics Sweden AB

2.78k

-2.06m

2.45m

DiaGenic ASA

19.62k

-5.20m

4.03m

19

Euroimplant SA

1.71k

-1.56m

4.46m

18

Fornix Biosciences NV

157.00k

-448.00k

2.82m

Genovis AB

710.05k

-1.78m

5.34m

13

Wntresearch AB

234.29k

-664.10k

5.28m

Yield Life Science publ AB

131.90k

-68.03k

4.80m

-32768

KEY INFORMATION

CIPAN-PORTUGAL

Company

Return on Average
Assets (TTM)

Return on Average Assets Return on Investment Return on Investment (5

(5 Year Average)
(TTM)
Year Average)

Akers Biosciences, Inc.

-48.7541

-44.2433

-52.844

-44.2433

Ark Therapeutics Group plc

-29.7397

-33.4283

-38.5853

-33.4283

B.M.P. Pharma Trading AG

--

-5.0834

--

-5.0834

-196.0199

-375.2577

-1,094.44

-375.2577

--

-5.7372

--

-5.7372

Creative Antibiotics Sweden AB

-74.7757

--

-81.9546

--

DiaGenic ASA

-68.0932

-76.0319

-75.333

-76.0319

Euroimplant SA

-21.1535

--

-25.5146

--

-4.5965

10.77

-5.3207

10.77

-60.8332

-100.3244

-69.1418

-100.3244

Wntresearch AB

-90.774

--

-114.3272

--

Yield Life Science publ AB

-3.6942

-8.421

-3.8196

-8.421

ChronTech Pharma AB
CIPAN - Cia Ind Prom de Ant SA

Fornix Biosciences NV
Genovis AB

MANAGEMENT EFFECTIVEMNESS

CIPAN-PORTUGAL

Company

Revenue (Year-overyear change%)

Net Income
(Year-over-year
change%)

Revenue (5 yr growth
rate)

Net Income (5 Yr Capital expenditure (

growth rate)
5 yr growth rate)

-41.536

11.84

-289.6465

--

-38.9093

Ark Therapeutics Group plc

841.74

83.36

76.5

--

-30.9316

B.M.P. Pharma Trading AG

-32.0875

26.66

-66.3105

--

--

--

--

2.48

--

--

7.61

1.24

101.39

-15.6935

-36.4096

183.11

120.04

16.9

--

-34.8482

-87.1476

--

-181.6286

--

--

139.45

-54.3329

53.1

--

--

Genovis AB

-9.2698

101.98

-20.515

--

-25.6713

Pharco SA

1,742.42

--

90.24

--

--

--

--

-133.2211

--

--

82.63

-29.3011

59.49

--

--

Akers Biosciences, Inc.

ChronTech Pharma AB
CIPAN - Cia Ind Prom de Ant SA
DiaGenic ASA
Euroimplant SA
Fornix Biosciences NV

Wntresearch AB
Yield Life Science publ AB

GROWTH RATES

CIPAN

Company
1.24

Industry
10.41

Sector
12.25

EPS - 5 Yr. Growth Rate

-20.81

4.05

4.47

Capital Spending - 5 Yr.

Growth Rate

-36.41

10.17

9.79

Sales - 5 Yr. Growth

Rate

FINANCIAL PERFORMANCE

CIPAN

Company
42

Industry
62.35

Sector
59.45

46.66

59.03

56.76

EBITD - 5 Yr. Avg

4.33

24.6

22.1

Operating Margin
(TTM)
Operating Margin 5 Yr. Avg.

-12

6.31

3.55

-4.07

18.99

16.05

Pre-Tax Margin - 5
Yr. Avg.

-8.96

19.56

16.44

Net Profit Margin - 5

Yr. Avg.

-7.07

14.59

11.72

Gross Margin (TTM)

Gross Margin - 5 Yr.
Avg.

PROFITABILITY RATIOS

CIPAN

Company
-3.24

Industry
9.62

Sector
8.71

Return on Investment - 5
Yr. Avg.

-5.74

12.15

10.94

Return on Equity - 5 Yr.

Avg.

-7.89

14.49

13.12

Return on Assets - 5 Yr.

Avg.

MANAGEMENT EFFECTIVENESS

CIPAN

35.2
10.8642

20.2%

MANAGEMENT EFFECTIVENESS